425 related articles for article (PubMed ID: 27582113)
21. Optical coherence tomography findings of very late stent thrombosis after drug-eluting stent implantation.
Ko YG; Kim DM; Cho JM; Choi SY; Yoon JH; Kim JS; Kim BK; Choi D; Jang Y; Hong MK
Int J Cardiovasc Imaging; 2012 Apr; 28(4):715-23. PubMed ID: 21656060
[TBL] [Abstract][Full Text] [Related]
22. Difference in neointimal coverage at chronic stage between bare metal stent and sirolimus-eluting stent evaluated at stent-strut level by optical coherence tomography.
Ikuta S; Kobuke K; Iwanaga Y; Nakauchi Y; Yamaji K; Miyazaki S
Heart Vessels; 2014 May; 29(3):320-7. PubMed ID: 23793881
[TBL] [Abstract][Full Text] [Related]
23. Very long-term follow-up of strut apposition and tissue coverage with Biolimus A9 stents analyzed by optical coherence tomography.
Staico R; Costa MA; Chamié D; Bezerra H; Armaganijan LV; Costa RA; Costa JR; Siqueira D; Centemero M; Chaves Á; Tanajura LF; Abizaid A; Feres F; Sousa JE; Sousa AG
Int J Cardiovasc Imaging; 2013 Jun; 29(5):977-88. PubMed ID: 23456358
[TBL] [Abstract][Full Text] [Related]
24. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.
Tada T; Byrne RA; Simunovic I; King LA; Cassese S; Joner M; Fusaro M; Schneider S; Schulz S; Ibrahim T; Ott I; Massberg S; Laugwitz KL; Kastrati A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1267-74. PubMed ID: 24355117
[TBL] [Abstract][Full Text] [Related]
25. Intravascular ultrasound assessment of minimum lumen area and intimal hyperplasia in in-stent restenosis after drug-eluting or bare-metal stent implantation. The Nordic Intravascular Ultrasound Study (NIVUS).
Jensen LO; Vikman S; Antonsen L; Kosonen P; Niemelä M; Christiansen EH; Kervinen K; Erglis A; Harnek J; Kumsars I; Thuesen L; Niemelä K
Cardiovasc Revasc Med; 2017 Dec; 18(8):577-582. PubMed ID: 29066343
[TBL] [Abstract][Full Text] [Related]
26. Very early tissue coverage after drug-eluting stent implantation: an optical coherence tomography study.
Takahara M; Kitahara H; Nishi T; Miura K; Miyayama T; Sugimoto K; Nakayama T; Fujimoto Y; Kobayashi Y
Int J Cardiovasc Imaging; 2017 Jan; 33(1):25-30. PubMed ID: 27601229
[TBL] [Abstract][Full Text] [Related]
27. In vivo optical coherence tomography of very late drug-eluting stent thrombosis compared with late in-stent restenosis.
Miyazaki S; Hiasa Y; Takahashi T; Yano Y; Minami T; Murakami N; Mizobe M; Tobetto Y; Nakagawa T; Chen PM; Ogura R; Miyajima H; Yuba K; Hosokawa S; Kishi K; Ohtani R
Circ J; 2012; 76(2):390-8. PubMed ID: 22130319
[TBL] [Abstract][Full Text] [Related]
28. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
[TBL] [Abstract][Full Text] [Related]
29. Strut coverage and vessel wall response to zotarolimus-eluting and bare-metal stents implanted in patients with ST-segment elevation myocardial infarction: the OCTAMI (Optical Coherence Tomography in Acute Myocardial Infarction) Study.
Guagliumi G; Sirbu V; Bezerra H; Biondi-Zoccai G; Fiocca L; Musumeci G; Matiashvili A; Lortkipanidze N; Tahara S; Valsecchi O; Costa M
JACC Cardiovasc Interv; 2010 Jun; 3(6):680-7. PubMed ID: 20630463
[TBL] [Abstract][Full Text] [Related]
30. IVUS Findings in Late and Very Late Stent Thrombosis. A Comparison Between Bare-metal and Drug-eluting Stents.
Fuentes L; Gómez-Lara J; Salvatella N; Gonzalo N; Hernández-Hernández F; Fernández-Nofrerias E; Sánchez-Recalde Á; Alfonso F; Romaguera R; Ferreiro JL; Roura G; Teruel L; Gracida M; Marcano AL; Gómez-Hospital JA; Cequier Á
Rev Esp Cardiol (Engl Ed); 2018 May; 71(5):335-343. PubMed ID: 28870640
[TBL] [Abstract][Full Text] [Related]
31. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.
Li S; Gai L; Yang T; Zhang L; Xu X; Bai Q; Xu H; Wang Y
Catheter Cardiovasc Interv; 2013 Apr; 81(5):768-75. PubMed ID: 22639418
[TBL] [Abstract][Full Text] [Related]
33. Vulnerable struts with CRE8, Biomatrix and Xience stents assessed with OCT and their correlation with clinical variables at 6-month follow-up: the CREBX-OCT study.
Giglioli C; Formentini C; Romano SM; Cecchi E; Baldereschi GJ; Landi D; Chiostri M; Prati F; Marchionni N
Int J Cardiovasc Imaging; 2020 Feb; 36(2):217-230. PubMed ID: 31667661
[TBL] [Abstract][Full Text] [Related]
34. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
[TBL] [Abstract][Full Text] [Related]
35. Different Neoatherosclerosis Patterns in Drug-Eluting- and Bare-Metal Stent Restenosis - Optical Coherence Tomography Study.
Nakamura D; Yasumura K; Nakamura H; Matsuhiro Y; Yasumoto K; Tanaka A; Matsunaga-Lee Y; Yano M; Yamato M; Egami Y; Shutta R; Sakata Y; Tanouchi J; Nishino M
Circ J; 2019 Jan; 83(2):313-319. PubMed ID: 30487370
[TBL] [Abstract][Full Text] [Related]
36. Tissue coverage of paclitaxel and sirolimus eluting stents in long term follow-up: optical coherence tomography study.
Kochman J; Pietrasik A; Rdzanek A; Ścibisz A; Pawlak M; Filipiak KJ; Opolski G
Cardiol J; 2013; 20(3):247-53. PubMed ID: 23788298
[TBL] [Abstract][Full Text] [Related]
37. Short- and long-term benefits of drug-eluting stents compared to bare metal stents even in treatment for large coronary arteries.
Yoshida T; Sakata K; Nitta Y; Taguchi T; Kaku B; Katsuda S; Shimojima M; Gamou T; Nakahashi T; Konno T; Kawashiri MA; Yamagishi M; Hayashi K
Heart Vessels; 2016 May; 31(5):635-42. PubMed ID: 25758470
[TBL] [Abstract][Full Text] [Related]
38. Delayed coverage of drug-eluting stents after interventional revascularisation of chronic total occlusions assessed by optical coherence tomography: the ALSTER-OCT-CTO registry.
Heeger CH; Busjahn A; Hildebrand L; Fenski M; Lesche F; Meincke F; Kuck KH; Bergmann MW
EuroIntervention; 2016 Jan; 11(9):1004-12. PubMed ID: 25287264
[TBL] [Abstract][Full Text] [Related]
39. Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.
Sabbah M; Kadota K; El-Eraky A; Kamal HM; Abdellah AT; El Hawary A
Int J Cardiovasc Imaging; 2017 Oct; 33(10):1463-1472. PubMed ID: 28444549
[TBL] [Abstract][Full Text] [Related]
40. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]